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The progressive public and governmental awareness that
we live in a chemical world, where both natural and man-
made substances impose specific risks to living organisms,
raised the need for regulatory and interventional measures
to protect human health. Naturally, regulatory measures
depend on identification of the hazard and the risk
imposed by suspected chemicals. In the absence of human
data, laboratory models have been used to identify target
organs, adverse effects, and critical toxicological doses, all
of which contribute to subsidize specific regulations.
A case study is presented to illustrate how basic research
can contribute to regulatory measures aiming to control
human cancer risk due to environmental contaminants.
Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) is a
substituted urea herbicide acting through inhibition of
plant photosynthesis. In a 2-yr long experiment, Wistar
rats fed diuron at 2,500 ppm (about 157 mg/kg.day for
both sexes) developed urothelial carcinomas in the urinary
bladder. The non-observed effect level (NOEL) for carci-
nogenicity was 25 ppm (1.35 mg/kg.day), based on urothe-
lial hyperplasia and tumors [1]. Accordingly, the U.S.
Environmental Protection Agency evaluated diuron as a
“known/likely carcinogen to humans” [1,2]. Despite this
classification, the quantitative risk associated to diuron
was considered of no concern [2] and the herbicide is
worldwide applied on main agricultural crops such as soy,
cotton and sugar cane, among other uses. The impact of
chronic low-dose exposure to diuron on human health has
not been determined.
The standard procedure for identifying chemical carci-
nogens is the long-term bioassay with rodents. Although
presenting a 40-year long history of usefulness, this 2-year
assay bears important limitations, such as high cost and
operational complexity, and also because it was not
designed to provide information about the toxicological
mode of action (MoA) of chemicals. As for any experi-
ment with laboratory animals, extrapolating the results to
the human situation is not a simple task, and may com-
promise human risk assessment. To inform risk assess-
ment, a framework was proposed for systematic and
detailed evaluation of the MoA in laboratory animals and
for evaluating the human relevance of experimental results
[3-5].
The genotoxic/mutagenic potentials of diuron are
accepted to be negative [1,6,7]. Therefore, the carcino-
genic MoA of diuron in the rat urinary bladder should
be predominantly non-genotoxic. In an early study, rats
fed diuron at 2,500 ppm during 20 weeks developed
urothelial necrosis – observed ultrastructurally -, regen-
erative cell proliferation and urothelial hyperplasia [6].
To test the hypothesis that urinary crystals and amor-
phous precipitates could act as microabrasives to the
mucosa causing cell death and regenerative hyperplasia
that lead to urothelial carcinogenesis, rats were fed
2,500 ppm of diuron either with or without NH4Cl
10,000 to acidify urine during 15 to 30 weeks [7].
Groups fed diuron+NH4 showed reduced amount of
urinary solids in the urine; nevertheless, urothelial
necrosis and simple hyperplasia (SH), a stochastic pre-
neoplastic urothelial lesion, were observed both in
diuron- and diuron+NH4Cl treated animals. Therefore,
chemically induced cytotoxicity and not abrasion by
urinary solids seems to be the initial key event for
diuron-induced rat urothelial carcinogenesis. These
urothelial lesions start at the very 1st day of exposure to
2,500 ppm and encompass cell swelling followed by
necrosis, exfoliation and piling up of cells indicative of
hyperplasia [8]. A recent study indicated that 500 ppm
can also induce urothelial citotoxicity [9].
Regarding dose-response and the molecular pathways
involved, rats were fed diuron at different concentrations
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from 60 ppm up to 2,500 ppm for 7 days and 20 weeks.
After 7 days no significant urothelial lesions were observed
by light or electron microscopy but gene expression profile
(Affymetrix microarrays) indicated altered pathways
related to cell-to-cell interactions in a dose-response man-
ner, suggesting that the early influence of diuron and/or
its metabolites on the urothelium may result in loss of
cell-to-cell adhesion and local tissue disorganization [10].
By the week 20th, rats fed 1,250 or 2,500 ppm, but not
those fed 125 ppm or lower, developed SH [11]. Accord-
ingly, gene expression data suggested that low levels of
diuron induced pathways involved in the maintenance of
cellular homeostasis while higher levels were associated to
increased cell metabolism, oxidative stress and cell death
followed by sustained hyperplasia. Although based on pre-
neoplastic alterations, these data allow indicating diuron at
1,250 ppm as potentially carcinogenic as 2,500 ppm and
assuming 125 ppm as a no effect level (NOEL) for urothe-
lial alterations [11].
This case study illustrates how translational non-clinical
research can help to understand and eventually control
environmentally-related human cancer hazards. Optical
and ultrastructural microscopies, genotoxicity assays, cell
proliferation assays, and genome-wide transcriptional pro-
filing disclosed key events of diuron-induced rat urothelial
cytotoxicity and potential carcinogenesis. They also indi-
cated that a threshold dose may exist below which no car-
cinogenic process is launched. Data still missing to
support sound quantitative human risk assessment refers
to the evaluation of human relevance of the key events
verified in rodents and the identification of the exposure
levels to which people are exposed.
Acknowledgments
Brazilian funding agencies FAPESP and CNPq provided grants to support
these studies. Researchers at the Nebraska University Medical Center
(UNMC), under Dr. S.M. Cohen, at the National Health and Environmental
Effects Research Laboratories (NHEERL), USEPA, under Dr. D.C. Wolf, and at
the Sao Paulo State Univ (UNESP), under Dr. J.L.V. de Camargo, gave support
and co-authored the studies described.
Published: 4 April 2013
References
1. APVMA: Diuron. Human health assessment. Australian Pesticides and
Veterinary Medicines Authority. Australian Government; 2011, 76.
2. USEPA: Registration Eligibility Decision (RED) for Diuron. US
Environmental Protection Agency. Office of Prevention, Pesticides and Toxic
Substances; 2003 [http://www.epa.gov/oppsrrd1/REDs/diuron_red.pdf],
Accessed on September 12th, 2012.
3. Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P,
Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice JM,
Younes M, International Programme on Chemical Safety: IPCS conceptual
framework for evaluating a mode of action for chemical carcinogenesis.
Regulatory Toxicology and Pharmacology 2001, 34:146-152.
4. Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L,
Bucher J, Longfellow DG, Seed J, Dellarco V, Fenner-Crisp P, Patton D:
Evaluating the human relevance of chemically induced animal tumors.
Toxicol Sci 2004, 78(2):181-6.
5. Carmichael N, Bausen M, Boobis AR, Cohen SM, Embry M, Fruijtier-Pölloth C,
Greim H, Lewis R, Bette Meek ME, Mellor H, Vickers C, Doe J: Using mode
of action information to improve regulatory decision-making: an
ECETOC/ILSI RF/HESI workshop overview. Crit Rev Toxicol 2011, 41:175-186.
6. Nascimento MG, de Oliveira ML, Lima AS, de Camargo JL: Effects of diuron
[3-(3,4-dichlorophenyl)-1,1-dimethylurea] on the urinary bladder of male
Wistar rats. Toxicology 2006, 224:66-73.
7. da Rocha MS, Nascimento MG, Cardoso AP, de Lima PL, Zelandi EA, de
Camargo JL, de Oliveira ML: Cytotoxicity and regenerative proliferation as
the mode of action for diuron-induced urothelial carcinogenesis in the
rat. Toxicol Sci 2010, 113(1):37-44.
8. da Rocha MS, Arnold LL, Pennington KL, Muirhead D, Dodmane PR,
Anwar MM, Battalora M, De Camargo JL, Cohen SM: Diuron-induced rat
bladder epithelial cytotoxicity. Toxicol Sci 2012.
9. Cardoso , et al: Dose-response study of diuron (3-(3,4-dichlorophenyl)-
1,1-dimethylurea) on the urinary bladder of male Wistar rats., in
preparation.
10. Ihlaseh , et al: Gene expression profiling of urinary bladder urothelium
from rats treated with diuron for seven days., in preparation.
11. Ihlaseh SM, Bailey KA, Hester SD, Jones C, Ren H, Cardoso AP, Oliveira ML,
Wolf DC, de Camargo JL: Transcriptional profile of diuron-induced toxicity
on the urinary bladder of male Wistar rats to inform mode of action.
Toxicol Sci 2011, 122(2):330-338.
doi:10.1186/1753-6561-7-S2-K10
Cite this article as: de Camargo: Chemical carcinogenesis – mode of
action to inform quantitative human risk. BMC Proceedings 2013
7(Suppl 2):K10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
de Camargo BMC Proceedings 2013, 7(Suppl 2):K10
http://www.biomedcentral.com/1753-6561/7/S2/K10
Page 2 of 2
